
The aim of the study was to verify the efficacy of vulvar Visnadine spray in premenopausal women affected by female sexual arousal disorder (FSAD). Thirty-eight women aged 25-40 years affected by FSAD were enrolled in the randomized crossover study, by two possible sequences: on-demand, washout, daily (A sequence); and daily, washout, on-demand (B sequence). The Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale (FSDS) were used to assess sexual function and sexual distress, respectively. Color Doppler ultrasonography was used to measure clitoral blood flow. The study had two follow-ups at 30 (T1) and 60 days (T2). Thirty-one women completed the study. Mean (SD) sexual activity and vulvar Visnadine spray usage was 1 ± 0.9 weekly during on-demand administration for both the sequences (Vs T0, p = NS). The mean sexual activity during daily usage was 2 ± 0.9 (Vs T0, p < .004) and 2 ± 0.8 (Vs T0, p < .001) for A and B sequences, respectively. FSFI total score, particularly genital arousal, improved more during the daily than during on-demand phases of both sequences (p < .001). Finally, clitoral blood flow improved significantly during daily usage of both the sequences (p < .001). Our study suggests that vulvar Visnadine spray could improve sexual performance of women affected by FSAD, producing changes in subjective and objective sexual aspects.
Adult, Patient Dropouts, Vaginal Diseases, Administration, Cutaneous, Clitoris, Drug Administration Schedule, Administration, Mucosal, Humans, Clitoral blood flow; female sexual arousal disorder; Visnadine; Endocrinology, Diabetes and Metabolism; Endocrinology; Obstetrics and Gynecology, Chromans, Ultrasonography, Doppler, Color, Aerosols, Psychiatric Status Rating Scales, Cross-Over Studies, Diagnostic and Statistical Manual of Mental Disorders, Sexual Dysfunction, Physiological, Regional Blood Flow, Vagina, Female, Stress, Psychological, Follow-Up Studies
Adult, Patient Dropouts, Vaginal Diseases, Administration, Cutaneous, Clitoris, Drug Administration Schedule, Administration, Mucosal, Humans, Clitoral blood flow; female sexual arousal disorder; Visnadine; Endocrinology, Diabetes and Metabolism; Endocrinology; Obstetrics and Gynecology, Chromans, Ultrasonography, Doppler, Color, Aerosols, Psychiatric Status Rating Scales, Cross-Over Studies, Diagnostic and Statistical Manual of Mental Disorders, Sexual Dysfunction, Physiological, Regional Blood Flow, Vagina, Female, Stress, Psychological, Follow-Up Studies
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 13 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
